5-chloro-2-methoxy-N-(2-(4-sulfamoylphenyl)ethyl)benzamide,
16673-34-0,
5-Chloro-2-methoxy-N-(4-sulfamoylphenethyl)benzamide,
NLRP3 Inflammasome Inhibitor I,
5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide,
4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulphonamide,
5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide,
N-(2-(4-(Aminosulphonyl)phenyl)ethyl)-5-chloro-2-methoxybenzamide,
4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulfonamide,
4-[2-(2-Methoxy-5-chlorobenzamido)ethyl]benzene sulfonamide,
4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide,
N-(2-(4-sulfamoyl)phenyl)ethyl-5-chloro-2-methoxybenzamide,
5-Chloro-2-methoxy-N-[2-(4-sulfamoyl-phenyl)-ethyl]-benzamide,
Glibenclamide impurity A (4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonamide),
SR-01000945190,
4-(2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL)PHENYLSULFONAMIDE,
EINECS 240-722-5,
BAS 00498400,
ACMC-209uxb,
Glibenclamide Impurity A,
5-Chloro-2-methoxy-N-[2-(4-sulfamoyl-,
phenyl)-ethyl]-benzamide,
EC 240-722-5,
AC1L39OX,
AC1Q3LT6,
DSSTox_CID_31449,
DSSTox_RID_97335,
DSSTox_GSID_57660,
Oprea1_786605,
Oprea1_846330,
nlrp3-Inflammasome-inhibitor-i,
DK-1,
IFLab1_000209,
SCHEMBL8993421,
Jsp003360,
CHEMBL3188223,
DTXSID1057660,
CTK4D2430,
AOB2464,
SYN5142,
KVWWTCSJLGHLRM-UHFFFAOYSA-N,
HMS1412J11,
ZINC641902,
BCP13822,
Tox21_113826,
ANW-44349,
STK039139,
AKOS000592467,
MCULE-7070512861,
VZ28081,
IDI1_008428,
NCGC00253706-01,
NCGC00253706-02,
AC-18743,
AJ-23806,
AS-16506,
BC214318,
ZB014723,
CAS-16673-34-0,
DB-043663,
TC-133094,
FT-0637396,
ST24029443,
ST50232470,
I06-1619,
SR-01000945190-1,
SR-01000945190-2,
W-107916,
5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]b,
4-[2-(5-Chloro-2-methoxybenzamido)ethyl] phenylsulphonamide,
5-chloro-2-methoxy-N-[2-(4-sulfamoyl-phenyl) ethyl]-benzamide,
N~1~-[4-(aminosulfonyl)phenethyl]-5-chloro-2-methoxybenzamide,
p-(2-{5-chloro-2-methoxybenzamido}ethyl)-benzene sulfonamide,
5-Chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide, 95%,
Benzamide,N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy-,
N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy-benzamide,
(5-chloro-2-methoxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]carboxamide,
4-[2-(2-Methoxy-5-chlorobenzene-1-carboxamido)ethyl]benzenesulfonamide,
Glibenclamide impurity A, European Pharmacopoeia (EP) Reference Standard,
Glyburide Related Compound A, United States Pharmacopeia (USP) Reference Standard,
C16H17ClN2O4S,
Glibenclamide EP Impurity A,
CID85542,
C16-H17-Cl-N2-O4-S,
AR-1G7743,
CS-O-13327,
CS-T-11856,
4-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfamide,
4-(2-methoxy-5-chlorobenzamidoethyl)benzenesulfonamide,
5-Chloro-2-methoxy-N-[2-(4-sulphamoylphenyl)ethyl]benzamide,
N-[2-[4-(aminosulphonyl)phenyl]ethyl]-5-chloro-2-methoxybenzamide,
Benzamide, N-(2-(4-(aminosulfonyl)phenyl)ethyl)-5-chloro-2-methoxy-,
169799-03-5,